On Monday, Pfizer and its German partner Bio-N-Tech announced that it had preliminary results for a vaccine that’s more than 90 percent effective.
It sounds like good news since we’ve been told by many experts that life can’t return to normal without an effective vaccine. But before we start tossing away our masks, there are still a lot of medical unknowns and ultimately … a lot of social policy decisions to make. How will life change? What will be the new, new normal?
We have with us James Sapirstein, CEO of Azurrx Biopharma Inc. and Clara Del Villar, health care policy analyst and director of senior initiatives with FreedomWorks.